About The Study: This study including 432,000 patients who underwent major surgery for eight cancer types found an increased rate of venous thromboembolism associated with cancer surgery. The risk persisted for about two to four months postoperatively but varied between cancer types. The increased rate is likely explained by the underlying cancer disease and adjuvant treatments. The results highlight the need for individualized venous thromboembolism risk evaluation and prophylaxis regimens for patients undergoing different surgery for different cancers.
Authors: Johan Björklund, M.D., Ph.D., of the Karolinska Institutet in Stockholm, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.54352)
